| Trademark Snap Shot Publication Stylesheet (Table presents the data on Publication Approval) |
|||
OVERVIEW |
|||
| SERIAL NUMBER | 90044720 | FILING DATE | 07/09/2020 |
| REG NUMBER | 0000000 | REG DATE | N/A |
| REGISTER | PRINCIPAL | MARK TYPE | TRADEMARK |
| INTL REG # | N/A | INTL REG DATE | N/A |
| TM ATTORNEY | SOLANO, CARLITA JAYE |
L.O. ASSIGNED | O10-NOT FOUND |
PUB INFORMATION |
|||
| RUN DATE | 08/22/2020 | ||
| PUB DATE | N/A | ||
| STATUS | 680-APPROVED FOR PUBLICATION | ||
| STATUS DATE | 08/21/2020 | ||
| LITERAL MARK ELEMENT | LUMAKRAS | ||
| DATE ABANDONED | N/A | DATE CANCELLED | N/A |
| SECTION 2F | NO | SECTION 2F IN PART | NO |
| SECTION 8 | NO | SECTION 8 IN PART | NO |
| SECTION 15 | NO | REPUB 12C | N/A |
| RENEWAL FILED | NO | RENEWAL DATE | N/A |
| DATE AMEND REG | N/A | ||
FILING BASIS |
|||||
| FILED BASIS | CURRENT BASIS | AMENDED BASIS | |||
| 1 (a) | NO | 1 (a) | NO | 1 (a) | NO |
| 1 (b) | YES | 1 (b) | YES | 1 (b) | NO |
| 44D | NO | 44D | NO | 44D | NO |
| 44E | NO | 44E | NO | 44E | NO |
| 66A | NO | 66A | NO | ||
| NO BASIS | NO | NO BASIS | NO | ||
MARK DATA |
|
| STANDARD CHARACTER MARK | YES |
| LITERAL MARK ELEMENT | LUMAKRAS |
| MARK DRAWING CODE | 4-STANDARD CHARACTER MARK |
| COLOR DRAWING FLAG | NO |
CURRENT OWNER INFORMATION |
|
| PARTY TYPE | 10-ORIGINAL APPLICANT |
| NAME | Amgen Inc. |
| ADDRESS | Trademark Operations - MS-28-5A One Amgen Center Drive Thousand Oaks, CA 913201799 |
| ENTITY | 03-CORPORATION |
| CITIZENSHIP | Delaware |
GOODS AND SERVICES |
|
| INTERNATIONAL CLASS | 005 |
| DESCRIPTION TEXT | Pharmaceutical preparations for use in the prevention of amyloidosis, metabolic diseases and disorders, lupus, and inflammation and autoimmune diseases and disorders; pharmaceutical preparations for use in the treatment of cancer, oncology, tumors, solid and hematological tumors and growths, hematological and hemolytic diseases and disorders, including bone, joint, vertebral column, intestine, colon, skin, lung, eye, breast, ovary, cervix, stomach, bladder, kidney, head, brain, neck, and blood diseases and disorders; pharmaceutical preparations for use in the treatment of amyloidosis, metabolic diseases and disorders, lupus, and inflammation and autoimmune diseases and disorders; pharmaceutical preparations for use in the treatment of solid tumors and growths, hemolytic diseases and disorders, amylodiosis, metabolic diseases and disorders, lupus, and inflammation and autoimmune diseases and disorders |
GOODS AND SERVICES CLASSIFICATION |
|||||||
| INTERNATIONAL CLASS | 005 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
MISCELLANEOUS INFORMATION/STATEMENTS |
|
| CHANGE IN REGISTRATION | NO |
PROSECUTION HISTORY |
||||
| DATE | ENT CD | ENT TYPE | DESCRIPTION | ENT NUM |
| 08/21/2020 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | 008 |
| 08/20/2020 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | 007 |
| 08/20/2020 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 006 |
| 08/20/2020 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | 005 |
| 08/20/2020 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | 004 |
| 08/17/2020 | DOCK | D | ASSIGNED TO EXAMINER | 003 |
| 08/05/2020 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 002 |
| 07/13/2020 | NWAP | I | NEW APPLICATION ENTERED IN TRAM | 001 |
CURRENT CORRESPONDENCE INFORMATION |
|
| ATTORNEY | Elsa D. Lemoine |
| CORRESPONDENCE ADDRESS | ELSA D. LEMOINE AMGEN INC. ONE AMGEN CENTER DRIVE TRADEMARK OPERATIONS-MS-28-5A THOUSAND OAKS, CA 91320-1799 |
| DOMESTIC REPRESENTATIVE | NONE |